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Abstract
Chinese tonic herbs are often used as remedies for the treatment of cancer or immunity related diseases. Cytokine regulation is
one of the pathways that modulates the immune system. In the present study, we investigated the effects of commonly used Chinese
herbs on cytokine regulation in human peripheral blood mononuclear cells (PBMC) and human acute monocytic leukemia cell line,
THP-1. Among the 15 selected Chinese herbs, Paeonia lactiflora exhibited inhibitory effect on phytohemagglutinin (PHA)-activated PBMC proliferation and induced IFN-γ production. We also used a multiplexed flow cytometric bead-based assay to analyze
the release of 17 cytokines and reverse transcription polymerase chain reaction (RT-PCR)/quantitative real-time PCR (qRT-PCR) to
evaluate gene expression. Cuscuta chinensis induced both interleukin-8 and MIP-1β release in THP-1 cells and influenced mRNA
transcription. Dioscorea opposita, Cinnamomum osmophloeum, and Glycyrrhiza uralensis enhanced secretion of granulocytemacrophage colony-stimulating factor (GM-CSF) and influenced GM-CSF gene expression. As such, different Chinese tonic herbs
may regulate immunomodulatory functions in human cells via diverse processes such as the modulation of different cytokines and
may be used as adjuvant immunity-boosting drugs. The present study is the first to use high-throughput multiplexed flow cytometric method to analyze cytokine regulatory effects of herbal extracts.
Key words: Chinese tonic herbs, human peripheral blood mononuclear cells, THP-1, multiplexed flow cytometric bead-based assay,
RT-PCR, quantitative real-time PCR

Introduction
Cytokines are messengers of the immune system
that modulate immunity and recombinant cytokine
proteins have been employed for the treatment of
cancer (1,2). Various cytokines are produced by activated monocytes and macrophages, including tumor
necrosis factor-α (TNF-α) and interleukin (IL)-1, IL-6,
and IL-8(3,4). These cytokines share similar functions
because redundancy is a characteristic of these proteins.
To modulate the secretion of pro-inflammatory cytokines, such as IL-2, IL-6, IL-12, granulocyte-macrophage-CSF (GM-CSF), interferon (INF)-γ, MIP-1β, and
TNF-α, the cytokine network balance probably plays
critical roles in cancer or immunity related diseases(5-7).
Researchers have used cytokines to enhance
* Author for correspondence. Tel: +886-2-27361661 ext. 6151; Fax:
+886-2-2735-7983; E-mail: Lmh@tmu.edu.tw

immunity, and several reports have suggested that they
can have a positive effect on cancer (7). Some of the cytokines currently under investigation for use in cancer
therapy include IL-2, IL-4, IL-12, IFN- γ, GM-CSF,
and TNF-α (8,9). IL-8 and macrophage inflammatory
protein-1β (MIP-1β) belong to a small family of cytokines called chemokines that are involved in promoting
chemotaxis (10). IL-8 is known as a pro-inflammatory
chemokine induced by stress or pro-inflammatory cytokines. Activation of IL-8 induces angiogenesis in endothelial cells and migration of neutrophils (10). MIP-1β
plays an important role in the regulation of immune
responses that enhance the development of humoral,
cellular, mucosal, and systemic immunity (11). MIP-1β
has also been shown to induce lymphocyte migration in
the nasal mucosa and is highly presented by influenza
virus-infected bronchial and nasal epithelial cells (12).
GM-CSF is one of the cytokines that stimulates the
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proliferation of neutrophils and monocyte-lineage cells.
Evidence has demonstrated that GM-CSF effectively
mobilizes bone marrow-derived progenitor cells into
the peripheral circulation (13). These mobilized progenitor cells can reconstitute bone marrow by transplantation after myeloablative treatment for hematological
malignancies. In addition to its hematopoietic effect,
GM-CSF improves the immune response by inducing the
proliferation, maturation, and recruitment of dendritic
cells as well as the expansion and differentiation of B
and T lymphocytes (14). Studies have demonstrated that
GM-CSF can exert therapeutically beneficial effects,
e.g. a high local GM-CSF concentration enhances
dendritic cell presentation of tumor antigens (15).
Traditional Chinese tonic herbs have been known
for their tonifying actions in the treatment of Yin, Yang,
Qi, and blood deficiencies. These herbs are used for
replenishing energy and treating functional deficiencies
of the spleen and lungs as well as blood deficiencies in
combination with blood tonics. They are also used for
nourishing the blood and replenishing the vital essences
and body f luids (16). In previous reports, various herbal
medicines were reported to possess immunomodulating
properties that may be useful for reducing the risk of
various diseases and cancers (17).
The aim of the present study was to investigate
the cytokine regulatory actions of Chinese tonic herbs.
We examined the effect of selected Chinese herbs on
the proliferation of peripheral blood mononuclear cells
(PBMCs) as well as on cytokine release from monocytes
using THP-1 cells as a model. Analysis was performed
using a f low cytometric bead-based assay and reverse
transcription polymerase chain reaction (RT-PCR)/quantitative real-time PCR (qRT-PCR).

Materials and methods
I. Herbal Materials
Herbal materials were collected from local medicinal markets in Taipei and identified by Dr. H.C. Chang
of the Graduate Institute of Pharmacognosy, Taipei
Medical University. The specimens were stored at the
laboratory of Taipei Medical University.

II. Preparation of Herbal Medicines
The dried herbal medicines were pulverized and
extracted with a 10-fold 95% ethanol solution at room
temperature for 3 days and then filtered three times.
The filtrates were combined and concentrated under
reduced pressure, freeze-dried, and stored in a closed
container. The test samples were dissolved in DMSO.
The final concentration of DMSO was less than 0.5% in
the medium.

III. Human Subjects
Blood was collected from healthy male subjects,
26-37 years of age. The experimental protocol was
reviewed and approved by the Institutional Human
Experimentation Committee. Written informed consent
was obtained from each subject.
IV. Preparation of PBMCs
PBMCs were prepared from heparinized, human
peripheral blood (50 mL) obtained from healthy volunteers using the Ficoll-Hypaque gradient density method
as described previously (18). Briefly, peripheral blood
was centrifuged at 2000 rpm at 4°C for 10 min to remove
the plasma. Blood cells were then diluted with phosphate-buffered saline (PBS) and centrifuged in a FicollHypaque gradient at 1500 rpm for 30 min. The PBMC
layers were collected and washed with cold, distilled
water and 10 × Hank’s buffer saline solution (HBSS) to
remove the red blood cells. The cells were then resuspended at 2 × 10 6 cells/mL in RPMI-1640 medium
supplemented with 2% fetal calf serum (FCS), 100 U/mL
penicillin, and 100 μg/mL streptomycin.

V. Lymphoproliferation Test
The lymphoproliferation test was modified from
that previously described (18). The density of PBMCs was
adjusted to 2 × 10 6 cells/mL before use. Cell suspensions (100 μL), with or without phytohemagglutinin
(PHA; Sigma, St. Louis, MO, USA) (0.25 or 5 μg/mL),
were distributed to 96-well plates. Various extracts
of the selected Chinese herbs were added to the cells.
The plates were incubated in a 5% CO2-air humidified
incubator at 37°C for 3 days. Subsequently, tritiated
thymidine (1 μCi/well; New England Nuclear, Boston,
MA, USA) was added to each well. After 16 h of incubation, the cells were harvested on glass fiber filters
using an automatic harvester (Dynatech, Multimash
2000, Billingshurst, UK). Radioactivity in the filters
was measured using a scintillation counter. Inhibition
of PBMC proliferation by each tested sample was calculated using the following formula:
Inhibitory activity (%) = (control group [CPM] experimental group [CPM])/(control group [CPM]) × 100.

VI. Determination of IFN-γ Production in PBMCs
PBMCs (2 × 105 cells/well) were cultured with
PHA alone or in combination with varying concentrations of the tested samples (6.25, 12.5, 25, 50, and 100
μg/mL) for 3 days. The cell supernatants were then
collected and assayed for IFN-γ concentrations using
an enzyme immunoassay (R&D Systems, Minneapolis,
MN, USA) (19).
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VII. Cells and Cell Cultures
The human monocytic cell line, THP-1, was
obtained from the American Type Culture Collection
(Rockville, MD, USA). THP-1 cells were maintained
in RPMI-1640 (Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (Sigma), L-glutamine (200 mmol/L), and 2-mercaptoethanol (5 × 105
mol/L; Sigma). One percent penicillin/streptomycin
(Sigma) was incorporated into the growth medium and
the cells were grown at 37°C in an environment of 5%
CO2 .

VIII. MTT Assay
Cell viability was assessed using an MTT assay(20).
THP-1 cells (1.0 × 105) were incubated in a 24 -well
plate in RPMI 1640 medium with 10% FBS per well for
24 h. The cells were treated with or without the herbal
samples and cultured for an additional 24 h. After centrifuging at 1000 rpm for 10 min, the supernatants were
removed. MTT (5 mg/mL; 20 μL) and 180 μL of medium
were added and cultured for 24 h, then transferred with
an Eppendorf (Hamburg, Germany) pipette. After centrifuging at 1000 rpm for 10 min and removing the supernatant, DMSO (200 μL) was added and mixed completely.
The mixture was transferred to an ELISA plate and
measured at 570 nm using a model µQuant microplate
reader (BioTek, Winooski, VT, USA).

IX. Cytokine Analyses Using Multiplexed Flow Cytometric
Bead-Based Assays
We investigated the production of inflammatory
cytokines in the culture media of untreated or herbal
medicine-treated (100 μg/mL for 24 h) THP-1 cells
using different flow cytometric bead-based assays (21).
The multiplexed analyses of cytokines with the BioPlex system used a liquid suspension array of 17 sets of
5.5 μm beads (Bio-Plex Human Cytokine 17-plex panel;

Bio-Rad, Hercules, CA, USA) internally dyed with
different ratios of two spectrally-distinct fluorochromes.
Eight point standard curves, ranging from 0.2 to 3200
pg/mL, were obtained by serial dilution of the reconstituted lyophilized standards. Data were analyzed using
the Bio-Plex manager software (Bio-Rad). The supernatant was frozen at -80°C until simultaneously analyzed
for the following 17 cytokines: IL-1β, IL-2, IL-4, IL-5,
IL-6, IL-7, IL-8, IL-10, IL-12 (p70), IL-13, IL-17, G-CSF,
GM-CSF, IFN-γ, MCP-1 (MCAF), MIP-1β, and TNF-α.
This was achieved using a custom 17-plex fluid-phase
immunoassay (Bio-Rad) run on a Bio-Plex Suspension Array System (Bio-Plex 100 System; Bio-Rad). A
Luminex-100 cytometer (Luminex Corporation, Austin,
TX, USA) was used and equipped with StarStation software (Applied Cytometry Systems, Dinnington, UK). All
samples were analyzed in triplicate. Cytokine levels were
expressed as picograms per milliliter.

X. RNA Isolation and Reverse Transcription
Total RNA was isolated using a High Pure RNA
Isolation Kit (Roche, Basel, Switzerland) according to
the manufacturer’s instructions. The quality of the total
RNA was evaluated based on the A260/A280 ratio. To
prepare a cDNA pool from each RNA sample, total
RNA (1 µg) was reverse transcribed using a Transcriptor
First Strand cDNA Synthesis Kit (Roche). Each cDNA
pool was stored at -20°C until qRT-PCR analysis was
performed.

XI. PCR Primers
Specific oligonucleotide primer pairs for qRT-PCR
were selected from the Roche Universal ProbeLibrary.
The ProbeFinder software (www.universalprobelibrary.
com) was used to design an optimal assay composed of
the respective labeled probe from the Universal ProbeLibrary Set as well as human and gene-specific primers
(Table 1).

Table 1. Primer sequences and reaction conditions for GM-CSF, MIP-1β, IL-8, and GAPDH.
Forward primer

Reverse primer

PCR condition

GM-CSF
(for qRT-PCR)

tctcagaaatgtttgacctcca

gcccttgagcttggtgag

55 cycles of 10 s at 95°C, 30 s
at 60°C, and 1 s at 72°C

MIP-1β
(for RT-PCR)

CCAAACCAACCGAAGCAAGC

ACAGTGGACCATCCCCATAG

33 cycles of 15 s at 94°C, 30 s
at 49°C, and 40 s at 68°C

IL-8
(for RT-PCR)

ATGACTTCCAAGCTGGCCGTG TTATTGAATTCTCAGCCCTCTTCAAAAACTTCTC

37 cycles of 15 s at 94°C, 30 s
at 55°C, and 40 s at 68°C

GAPDH
(for RT-PCR)

ACCACAGTCCATGCCATCAC

TCCACCACCCTGTTGCTGTA

29 cycles of 15 s at 94°C, 30 s
at 59°C, and 40 s at 68°C

GAPDH
(for qRT-PCR)

agccacatcgctcagacac

gcccaatacgaccaaatcc

55 cycles of 10 s at 95°C, 30 s
at 60°C, and 1 s at 72°C

Voucher
specimen

M215

M118

M197

M11

M82

M25

M21

M5

M9

M195

M28

M19

M-222

M-219

M18

No.

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Compositae
Convolvulaceac
Cynomoriaceae
Dioscoreaceae
Lauraceae
Leguminosae
Leguminosae
Liliaceae
Liliaceae
Liliaceae
Liliaceae
Ranunculaceae

Rubiaceae

Scrophulariaceae
Umbelliferae

Cuscuta chinensis Lam.

Cynomorium songaricum Rupr.

Dioscorea opposita Thunb.

Cinnamomum osmophloeum Kaneh

Astragalus membranaceus (Fisch.) Bge.

Glycyrrhiza uralensis Fisch.

Lilium lancifolium Thunb.

Ophiopogon japonicus (Thunb.)
Ker.-Gawl.

Polygonatum odoratum (Mill.) Druce

Polygonatum sibiricum Red.

Paeonia lactiflora Pall.

Morinda officinalis How

Rehmannia glutinosa Libosch.

Angelica sinensis (Oliv.) Diels

Family

Atractylodes macrocephala Koidz

Species

Table 2. Traditional uses of the selected Chinese tonic herbs.

32.7

30.7

10.4

19.4

45.8

2.4

33.5

12.3

24.0

17.1

10.3

16.7

7.6

1.7

4.7

Yield (%)

Radix

Radix

Radix

Radix

Rhizoma

Rhizoma

Radix

Bulbus

Radix

Radix

Herba

Rhizoma

Stem

Semen

Rhizoma

Used Part

367
31
259

Protracted diarrhea, chronic enteritis, cough, and
dyspnoea
Stomach pain, diarrhea, cough, shock, pain, and
cold feeling in the lower part of the body
Perspiration caused by weakness, general
fatigue, and chronic diarrhea

296

314

Impotence, seminal emission, menstrual
disorders, pain in the lower abdomen, rheumatic
arthralgia, and weakness of the extremities
Anemia, weakness, and low-grade afternoon
fever

251

299

Menstrual disorders and dysfunctional uterine
bleeding

Anemia and menstrual disorders

385

386

Hyperlipidemia, fever, cough, dizziness, and
muscular spasm
General weakness and dry cough

298

8

Cough, anxiety, pharyngitis, and hemoptysis

Cough, hemoptysis, palpitation, forgetfulness,
and convalescence of febrile diseases

286

164

Impotence, emission, and weakness and
paralysis of extremities

Sore throat, cough, hysteria, dermatitis, and boils

406

352

Page

Weakness in lower body and legs and poor vision

Anorexia, abdominal distension, and weakness

Indication (22)
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XII. RT-PCR
The obtained cDNAs were amplified using the
primers shown in Table 1. The reaction conditions are
shown in Table 1. The resulting products were analyzed
by electrophoresis on 1.5% agarose gels and staining with
ethidium bromide. Specific primers for GAPDH were
used as controls.

XIII. qRT-PCR
qRT-PCR reactions were performed on the Roche
LightCycler 2.0 instrument using LightCycler TaqMan
Master Mix (Roche Cat. 04 535 286 001). The ProbeFinder software (www.universalprobelibrary.com) was
used to design the optimal assay comprised of the respective labeled probe from the Universal ProbeLibrary Set
and human and gene-specific primers. Briefly, 20 µL
of reactions contained 5 µL of cDNA template, 4 µL of
Master Mix, 0.2 µL of 10 µM probe, 0.4 µL of 10 µM
forward primer, 0.4 µL of 10 µM reverse primer, and 10
µL of water. The RT-PCR program was 95°C for 10 min,
45 cycles of 95°C for 10 sec, 72°C for 1 sec, and 40°C for
30 sec. At the end of the program, a melt curve analysis
was performed. At the end of each RT-PCR run, the data
were automatically analyzed and an amplification plot
was generated for each cDNA sample. From each of these
plots, the LightCycler4 data analysis software automatically calculated the CP value (crossing point: the turning
point corresponds to the first maximum of the second
derivative curve), which indicated the beginning of exponential amplification. The mRNA level was normalized
with reference to the amount of the GAPDH mRNA.

XIV. Statistical Analysis
Differences between the data sets were tested for
significance using one-way ANOVA followed by Scheffe
test. p < 0.05 indicated significantly different data sets.

Results
Chinese herbs have been used in alternative medicine for centuries. They are often used to maintain human
health and treat diseases. In the present study, we selected
Chinese tonic herbs based on compiled ethnobotanical
data, which revealed that they have tonifying actions for
the treatment of deficiencies in the body (Table 2)(22). We
then evaluated their effects on the regulation of cytokines
in PBMCs and THP-1 cells. Many active components
from Chinese herbs were extracted by ethanol-water solution(23-25). Thus, Chinese herbs were extracted with 95%
EtOH in the present study. The ethanolic extracts were
derived from 11 families, and yields of the 95% EtOH
extracts were between 1.7 and 45.8% (Table 2).

I. Inhibitory Effect of Chinese Herbs on PBMC Proliferation Induced by PHA
To evaluate the inhibitory effects of the selected
Chinese herbs on PBMC proliferation, unstimulated cells
or cells activated with PHA were treated with 100 μg/
mL of individual herbal extract. Cell proliferation then
was determined based on uptake of tritiated thymidine.
Among the 15 selected extracts, P. lactiflora significantly
inhibited PBMC proliferation stimulated with PHA (5 μg/
mL), although it had little effect on tritiated thymidine
uptake in resting PBMCs (Table 3). The inhibitory effect
of P. lactiflora on PBMCs was not related to direct cytotoxicity as the viabilities of resting and activated PBMC.

Table 3. Effects of the selected Chinese tonic herbs on PBMC
proliferation induced by PHA
Sample

Inhibitory Activity (%)
Unstimulated

PHA (5.0 μg/mL)

M215

77.5 ± 13.2

91.3 ± 4.3

M118

59.6 ± 3.6

80.3 ± 2.9

M197

23.7 ± 9.8

46.8 ± 4.0

M11

-19.1 ± 1.4

32.3 ± 4.1

M82

86.4 ± 2.7

95.4 ± 1.0

M25

20.3 ± 1.0

8.5 ± 0.2

M21

47.2 ± 6.8

62.7 ± 3.7

M5

4.6 ± 6.1

35.3 ± 6.4

M9

-3.8 ± 8.2

2.3 ± 7.9

M195

17.3 ± 4.3

38.2 ± 4.3

M28

-5.1 ± 1.0

9.1 ± 2.6

M19

18.5 ± 2.8

71.9 ± 2.8*

M222

32.4 ± 8.6

5.1 ± 4.3

M219

33.4 ± 8.1

38.7 ± 5.5

M18

-23.4 ± 6.3

18.2 ± 10.6

PBMCs (2 × 105/well) were treated with 100 μg/mL of the selected
Chinese herbal extracts and PHA (5 μg/mL) for 3 days. The proliferation of cells was estimated based on uptake of tritiated thymidine.
After incubation for 16 hr, the cells were harvested using an
automatic harvester, after which radioactivity was measured using a
scintillation counter. The inhibitory percentage was calculated using
the formula described in the Materials and Methods section. Data
were analyzed for statistical significance using the nonparametric
Mann-Whitney U-test. *: p < 0.05 versus unstimulated group.
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An MTT assay for cytotoxicity was employed
before further in vitro testing of THP-1 cells. Among
the 15 extracts tested, a relatively low cytotoxicity was
observed (Figure 2), with cell viability above 80% at
concentrations of 100 g/mL. After low cytotoxicity was
demonstrated as a first test for possible usefulness, the
appropriate extracts were further examined for their
effects on regulation of cytokines in human monocytes.

IV. Effects of the Selected Chinese Herbs and LPS on Cytokine Release from THP-1 Cells
In the present study, we examined the effects of LPS
(10 ng/mL) on the release of 17 cytokines from THP-1
cells using the Bio-Plex system (BioRad). Among these
cytokines, IL-2, IL-4, IL-5, IL-7, IL-10, IL-12, and IL-13
were not detected in the culture supernatants of cells
incubated with or without LPS (10 ng/mL) for 24 hours
(Table 4). Incubation of THP-1 cells with LPS resulted
in a significant increase in the release of IL-8, IFN-γ,
MCP-1 (MCAF), MIP-1β, and TNF-α. We also investigated the effects of the selected Chinese herbs on the
secretion of these 17 cytokines. THP-1 cells were cultured
with or without the selected Chinese herbs at 100 μg/
mL. The results showed increased secretion of both IL-8
and MIP-1β in the presence of C. chinensis (M-118). We
found the GM-CSF secretion increased significantly
when cultured with D. opposite (M-11), C. osmophloeum
(M-82), or G. uralensis (M-21). An increase in the secretion of MIP-1β was also observed in THP-1 cells cultured
with C. songaricum (M-197), D. opposita (M-11), C.
osmophloeum (M-82), A. membranaceus (M-25), L. lancifolium (M-5), or P. sibiricum (M-28).

V. Effects on GM-CSF, MIP-1β, and IL-8 mRNA Expression
in THP-1 Cells
To evaluate whether the induction of IL-8, MIP-1β,
and GM-CSF following treatment with the tested
Chinese herbs was due to increased gene expression, total cellular RNA was extracted from THP-1
cells in the presence or absence of 100 μg/mL of select
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Figure 1. IFN-γ production in PBMCs treated with P. lactif lora
(M-19). PBMCs (2 × 105 /well) were treated with various concentrations of M-19 with or without PHA (5 μg/mL) for 3 days. Cell supernatants were collected and IFN-γ concentrations were determined
using an enzyme immunoassay. Each point represents mean of three
independent experiments.
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III. Effects of the Selected Chinese Herbs on Viability of
THP-1 Cells

Resting cells
PHA activated cells

6000

IFN-γ Production (pg/mL)

To elucidate whether the impairment of activatedPBMC proliferation was related to IFN-γ production, we
incubated cells with or without P. lactiflora for 3 days.
Supernatants were then collected and the production of
IFN-γ was determined using an enzyme immunoassay.
As shown in Figure 1, the level of IFN-γ produced in P.
lactiflora-treated PBMCs increased in comparison with
resting cells.

Chinese herbs and used for RT-PCR or qRT-PCR analysis. The results were normalized to the levels of the
GAPDH mRNA. The MIP-1β and GAPDH mRNAs were
detectable in each sample-treated THP-1 cell culture.
Compared with controls, the levels of the MIP-1β

Cell viability (%)

II. Effects of P. lactiflora on IFN-γ Production in PBMC
Cultures

Sample (100 µg/mL)

Figure 2. Viability of THP-1 cells following treatment with Chinese
herbal medicines. Cells (1.0 × 105) were incubated in a 24-well plate
in RPMI 1640 medium with 10% FBS for 24 h. The cells were treated
with or without various concentrations of Chinese herbal medicines
and cultured for an additional 24 h. Cell viability was assessed using
an MTT assay. The values were measured at 570 nm using a model
µQuant microplate reader (BioTek, Winooski, VT, U.S.A.). Data were
analyzed for statistical significance using the nonparametric MannWhitney U-test. *: p < 0.05 versus control group.

ND

ND

20.22 ± 2.80*

IL-17

G-CSF

GM-CSF

20.76 ± 1.07*

ND

TNF-α

5.84 ± 0.92

MIP-1β

(MCAF)

MCP-1

ND

24.51 ± 1.47*

7.58 ± 0.96

9.44 ± 1.44

17.38 ± 4.64

ND

ND

20.11 ± 3.16

ND

ND

M5

ND

ND

M9

ND

21.21 ± 2.97

6.20 ± 1.57

9.74 ± 2.66

15.19 ± 3.90

ND

ND

ND

ND

ND

M 195

ND

39.50 ± 21.28

6.41 ± 0.42

6.90 ± 1.36

ND

ND

ND

ND

ND

ND

M 19

ND

19.21 ± 0.91

6.50 ± 0.74

3.90 ± 2.87

13.27 ± 2.34

ND

ND

13.52 ± 2.48

ND

24.49 ± 2.40*

5.69 ± 1.10

7.37 ± 2.04

14.07 ± 0.16

24.33 ± 1.66*

5.66 ± 0.29

4.94 ± 1.41

14.44 ± 1.20

ND

ND

ND

ND

M 197

11.69 ± 1.17

20.76 ± 13.30

ND

ND

M 28

42.00 ± 6.18*

9.12 ± 1.60

10.02 ± 4.72

ND

ND

ND

6.52 ± 0.00

1.09 ± 0.91

ND

ND

ND

M 118

52.45 ± 16.94*

20.12 ± 9.68

24.66 ± 4.20

5.31 ± 1.24

5.44 ± 0.70

5.22 ± 1.13

ND

ND

20.91 ± 2.80

ND

ND

M 215

11.50 ± 3.61

268.2 ± 98.64*

356181.53 ± 855.89*

2012.26 ± 276.47*

36.03 ± 14.53*

2.77 ± 2.13

6.67 ± 2.14

6.20 ± 3.07

5844.48 ± 1307.35*

14.02 ± 6.73

8.44 ± 1.91

LPS a (10 ng/mL)

ND

ND

M 222

ND

27.59 ± 15.74

5.73 ± 1.38

ND

5.20 ± 3.80

ND

ND

19.55 ± 15.67

ND

25.37 ± 4.37*

6.47 ± 1.55

5.93 ± 0.00

25.33 ± 7.36*

ND

ND

18.39 ± 1.66

ND

ND

M 11

ND

21.51 ± 3.00

4.48 ± 0.61

ND

9.86 ± 6.39

ND

ND

12.42 ± 2.91

ND

ND

M 219

ND

25.95 ± 3.99*

5.26 ± 1.03

4.42 ± 2.13

23.35 ± 3.01*

ND

ND

17.61 ± 1.47

ND

ND

M 82

ND

21.50 ± 2.99

6.48 ± 1.46

5.82 ± 5.58

17.00 ± 5.02

ND

ND

11.84 ± 2.87

ND

ND

M 18

ND

23.94 ± 2.60

5.43 ± 1.68

7.38 ± 0.68

16.6 ± 5.00

ND

ND

14.33 ± 0.86

ND

ND

M 25

Abbreviations: Med, medium only; LPS, lipopolysaccharide.
* Statistical significance (p < 0.05) between medium and tested groups using one-way ANOVA followed by the Scheffe Test.
ND: Data was beyond the standard curve of the assay. The standard curves ranged from 1.95–32000 pg/mL by serial dilution of the reconstituted lyophilized standards. Cytokine levels were analyzed
using a nonlinear regression routine, four-parameter logistic (4PL). IL-2, IL-4, IL-5, IL-7, IL-10, IL-12 (p70), and IL-13 were not detected in the experiment.

a

18.95 ± 7.32

IL-8

6.89 ± 1.36

ND

IL-6

IFN-γ

ND

IL-1β

(pg/mL)

M 21

ND

TNF-α

2.38 ± 0.25

MCP-1 (MCAF)

17.64 ± 6.65

2.19 ± 1.61

IFN-γ

MIP-1β

2.04 ± 0.55

ND

IL-17

GM-CSF

16.28 ± 6.55

IL-8

1.61 ± 0.41

ND

IL-6

G-CSF

ND

IL-1β

(pg/mL)

Med a

Table 4. Cytokine analyses following treatment with selected Chinese tonic herbs (100 mg/mL)
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Discussion
Chinese tonic herbs have traditionally been used to
treat various asthenia syndromes. In previous papers,
Chinese tonic herbs were found to enhance mitochondrial oxidative processes and exhibited antioxidant (26,27)
and antitumor potentials (28), primarily as a result of the
enhancement of mitochondrial ATP generation(27). They
have also been shown to affect the respiratory, renal,
hepatic, cardiovascular, immunologic, and nervous
systems as well as impact cancer, glucose metabolism,
and inflammatory conditions (29,30). In the present study,
we evaluated 15 Chinese herbal medicines that are typically used as folk remedies in the treatment of invigoration. We used PBMCs as the target model and multiplexed flow cytometric bead-based assays to measure
cytokine release from human monocytes. We demonstrated that P. lactiflora exhibited an inhibitory effect on
PHA-activated PBMC proliferation. PHA is a mitogen
for T lymphocytes(31) that binds N-acetylgalactosamine glycoproteins expressed on the cell surface, thus
promotes cell proliferation. In this study, T cells were the
major proliferating cells in PBMC cultures activated with
PHA. The inhibitory effect of P. lactiflora on PHA-activated PBMC proliferation could therefore be suggested
to suppress T-cell proliferation. As one of the presumed
mechanisms of P. lactiflora’s action on PBMCs, IFN-γ
induction may occur through autologous binding to the
PBMC receptor and subsequent induction of secondary
immune responses to suppress cell proliferation (32).
In this study, C. chinensis induced IL-8 and MIP-1β
expression, both of which may modulate the immune
system. IL-8 serves as a chemical signal that attracts
neutrophils to the site of inflammation and, therefore,
it is also known as a neutrophil chemotactic factor.
When the body encounters an antigen , IL-8 is released
to signal other immune cells to migrate to the site of
inflammation(33). Therefore, IL-8 is often associated
with inflammation. MIP-1β, a member of the cysteinecysteine (C–C) chemokine family, is a chemotactic factor
in the inflammatory processes (34). MIP-1β is able to

(A)

Med

LPS M-118 M-197 M-11 M-82

M-25 M-5

1.00

8.56

1.16

M-28

MIP 1β
2.15

0.85

2.10

0.40

0.78 0.19

GAPDH
(B)

Med LPS M-118

IL 8
1.00 5.14 1.63

GAPDH

Figure 3. Expression of (A) MIP-1β and (B) IL-8 mRNAs following
treatment of THP-1 cells with LPS or various Chinese herbal medicines, based on RT-PCR analysis. The findings were normalized to
the expression of the GAPDH mRNA. Measurements were conducted
in triplicate. Med: medium; LPS: 10 ng/mL; Chinese herbal medicines (100 μg/mL).

20

Ratio (CP of target gene/CP of GAPDH)

mRNA in cells treated with C. chinensis, D. opposita,
or P. sibiricum were higher. Laser densitometry analysis
demonstrated that the fold increase for cells treated with
C. chinensis, D. opposita, or P. sibiricum were 2.15, 2.10,
and 1.16, respectively (Figure 3A). The levels of the IL-8
mRNA also increased by 1.63 fold after treatment with
C. chinensis in THP-1 cells (Figure 3B). qRT-PCR was
used to measure the degree of GM-CSF mRNA expression (relative to GAPDH expression). D. opposita, C.
osmophloeum, and G. uralensis upregulated the levels of
the GM-CSF mRNA. Compared to the untreated control
values, D. opposita, C. osmophloeum, and G. uralensis
treatment increased expression of the GM-CSF mRNA
by 6.14, 14.38, and 1.19 fold, respectively (Figure 4).

*, #

15

10
*, #
5

0

Med

LPS

M-11

M-82

M-21

Sample

Figure 4. Expression of the GM-CSF mRNA following treatment
with Dioscorea opposita (M-11), Cinnamomum osmophloeum
(M-82), or Glycyrrhiza uralensis (M-21) based on qRT-PCR analysis. Findings were normalized to the expression of the GAPDH
mRNA. Med: medium only; LPS: 10 ng/mL; M-11, M-82, and M-21
(100 µg/mL). Data were analyzed for statistical significance using
the nonparametric Mann-Whitney U-test. *: p < 0.05 versus medium
only; #: p < 0.05 versus LPS group.

enhance the development of humoral, cellular, mucosal,
and systemic immunity. MIP-1β-mediated immunity is
fostered by different regulation of costimulatory molecule expression for support of humoral and cell-mediated
immune responses.
In our flow cytometric bead-based assays, we found
that D. opposita, C. osmophloeum, and G. uralensis
enhanced GM-CSF release compared to controls. Additionally, we analyzed the effects at the mRNA level and
found an induction of GM-CSF transcription. GM-CSF
has been used to assist patients with cancer undergoing
chemotherapy, in patients with AIDS during therapy,
and in patients after bone marrow transplantation(35).
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Furthermore, GM-CSF is widely used as an adjuvant
in clinical trials involving vaccination with autologous
tumor cells, peptides, and/or dendritic cells in the treatment of various human neoplasms(36). In some studies,
GM-CSF has appeared to facilitate immune response, but
in other studies no effect or even a suppressive effect has
been reported. Therefore, these three Chinese herbal medicines may be used as adjuvants for regulating the immune
system.
Chemical analysis of C. chinensis reported that it
contained abundant phenolic compounds such as flavonoids, lignans, and quinic acid derivatives (37). On the
other hand, acidic polysaccharide from C. chinensis
showed potent stimulating effects on lymphocyte proliferation(38) and exhibited immune enhancement activities,
most notably promoting the proliferation of T and B cells
in vitro (39). In other previous investigations, phenolic
compounds isolated from D. opposita exhibited cyclooxygenase inhibitory activity (40). Cinnamaldehyde and
some flavonol glycosides from C. osmophloeum showed
anti-inflammatory effects via inhibition of cytokine
production in murine macrophages (41,42). Licorice flavonoids of G. uralensis were reported to reduce the levels
of LPS-induced inflammatory cells in bronchoalveolar
lavage fluids(43In the present study, we selected human
PBMCs and monocyte-derived macrophage THP-1 cells
as target cells to elucidate the immunomodulatory activities of Chinese herbal extracts. PHA is a mitogen for T
lymphocytes that binds to N-acetylgalactosamine glycoproteins on the cell surface and activates proliferation
and cytokine production, including IL-2 and IFN-γ (44).
In this study, T cells were the major proliferating cells in
PBMC cultures activated with PHA. Thus, effects of P.
lactiflora on PHA-activated PBMC proliferation or IFN-γ
production could suggest immunomodulatory activities
on human T lymphocytes. Although the THP-1 cell line
is derived from human acute monocytic leukemia cells,
it exhibits macrophage-like characteristics and secretes
macrophage-derived cytokines such as GM-CSF and
MIP-1β upon stimulation with LPS. Thus, THP-1 cells
are particularly useful for studying the effects of Chinese
herbs on macrophage-specific cytokines (45). In the
present investigation, we demonstrated that D. opposita,
C. osmophloeum, and G. uralensis enhanced GM-CSF
secretion in THP-1 cells by modulation of GM-CSF
expression and these herbs were potential immunomodulators for macrophages.

conclusions
In this study, P. lactiflora was shown to exhibit
inhibitory effects on PHA-activated PBMC proliferation and induce IFN-γ production. C. chinensis induced
both IL-8 and MIP-1β release through upregulation of
mRNA transcription in human monocytes (THP-1). D.
opposita, C. osmophloeum, and G. uralensis were shown

to increase GM-CSF expression through enhanced transcription in THP-1 cells. Thus, Chinese tonic herbs may
modulate cytokine production in human cells in diverse
ways and demonstrate significant potential as adjuvant
immune-boosting drugs. The regulatory mechanisms
underlying these observations remain to be elucidated.
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